Braze Inc vs Heron Therapeutics Inc — how do they compare? Braze Inc trades at $28.05 (market cap $3.18B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Braze Inc is far larger — about 51.7× Heron Therapeutics Inc's market cap, and Braze Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| BRZE | HRTX | |
|---|---|---|
Market Cap | $3.18B | $61.47M |
Sector | Technology | Health |
52-Week High | $36.19 | $1.49 |
52-Week Low | $15.79 | $0.32 |
Enterprise Value | $2.87B | $168.21M |
Trailing returns across standard periods
Latest headlines on both assets
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries.
Read more on BRZE →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →